Concepedia
Statistics
Publications
2
Citations
79
H-Index
Active since
1999
Affiliations
Abbott Fund(Current)
Steve Tahir is an author at Abbott Fund specializing in drug discovery, medicine, and pharmacology.
Top concepts
MedicinePharmacologyDrug DiscoveryAngiogenesisAtherosclerosisPharmacotherapyDrug DevelopmentVascular BiologyMedicinal ChemistryBiomedical Engineering
Publications per year
1999–1999
Effect of novel CAAX peptidomimetic farnesyltransferase inhibitor on angiogenesis in vitro and in vivo
Wen‐Zhen Gu, Steve Tahir, Y.-C Wang et al. · European Journal of Cancer · 1999 · 48 citations
Angiogenesis, Medicine, Endothelial Dysfunction +7
Potent and orally bioavailable noncysteine-containing inhibitors of protein farnesyltransferase
David J. Augeri, Dave Janowick, Douglas Kalvin et al. · Bioorganic & Medicinal Chemistry Letters · 1999 · 31 citations · Full text
Medicinal Chemistry, Protein Farnesyltransferase, Medicine +5
1–2 of 2